Found: 7
Select item for more details and to access through your institution.
Author Correction: GL261 luciferase-expressing cells elicit an anti-tumor immune response: an evaluation of murine glioma models.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Book reviews.
- Published in:
- 2004
- By:
- Publication type:
- Book Review
TMOD-05. GLIOMA-261 LUCIFERASE-EXPRESSING CELL LINE STIMULATES AN IMMUNOGENIC RESPONSE SIGNATURE IN AN IMMUNOCOMPETENT MURINE MODEL.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi269, doi. 10.1093/neuonc/noy148.1118
- By:
- Publication type:
- Article
GL261 luciferase-expressing cells elicit an anti-tumor immune response: an evaluation of murine glioma models.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-67411-w
- By:
- Publication type:
- Article
Development of a "Geo-Tagged" tumor sample registry: intra-operative linkage of sample location to imaging.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 165, n. 3, p. 449, doi. 10.1007/s11060-023-04493-2
- By:
- Publication type:
- Article
Variations in attitudes towards stereotactic biopsy of adult diffuse midline glioma patients: a survey of members of the AANS/CNS Tumor Section.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 149, n. 1, p. 161, doi. 10.1007/s11060-020-03585-7
- By:
- Publication type:
- Article
Patient outcomes after implementation of transitional care protocols in elective neurosurgery: a systematic review and meta-analysis.
- Published in:
- Neurosurgical Review, 2024, v. 47, n. 1, p. 1, doi. 10.1007/s10143-024-02612-9
- By:
- Publication type:
- Article